Given that to our knowledge, there is no recent research in humans regarding the appetite-modulating actions of TRH, this is an area of opportunity in which TRH analogs can be used to decrease food intake in people with a dysregulation in the hedonic drive to eat, such as in patients with obesity or binge-like eating. The gene discussed is TRH; the disease is obesity disorder.